IQVIA Overview

  • Status
  • Public

  • Employees
  • 83,000

Employees
  • Stock Symbol
  • IQV

Stock Symbol
  • Investments
  • 110

  • Share Price
  • $238.82

  • (As of Thursday Closing)

IQVIA General Information

Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Contact Information

Website
www.iqvia.com
Formerly Known As
IMS Health, Quintiles IMS, IMS Consulting Group
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
IT Consulting and Outsourcing
Stock Exchange
NYS
Primary Office
  • 83 Wooster Heights Road
  • Danbury, CT 06810
  • United States
+1 (203) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IQVIA Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$238.82 $240.62 $194.67 - $285.61 $44.9B 187M 1.02M $6.10

IQVIA Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 52,525,658 64,820,885 45,795,508 41,258,745
Revenue 14,136,000 13,874,000 11,359,000 11,088,000
EBITDA 2,855,000 2,761,000 2,070,000 1,992,000
Net Income 1,160,000 966,000 279,000 191,000
Total Assets 24,413,000 24,689,000 24,564,000 23,251,000
Total Debt 13,052,000 12,438,000 12,904,000 12,041,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IQVIA Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IQVIA‘s full profile, request access.

Request a free trial

IQVIA Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a
Other Healthcare Services
Danbury, CT
83,000 As of 2022
00000
000000000 00000

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000000000
Morrisville, NC
00000 As of 0000
00000
00000000000 00000

000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
00000 0000000000 0000000000 0000000
Blue Bell, PA
0000 As of 0000
00.00
00000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IQVIA Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Syneos Health Corporation Morrisville, NC 00000 00000 00000000000 00000
0000000 000000 Private Equity-Backed Blue Bell, PA 0000 00.00 00000000000 00.00
00000 0000000 Corporation Dickinson, ND 00 000000000 -
0000000 Formerly PE-Backed Bethesda, MD 000 000000000000
00 0000000000 Corporation Evanston, IL 00000
You’re viewing 5 of 12 competitors. Get the full list »

IQVIA Patents

IQVIA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4009194-A1 Automated classification and interpretation of life science documents Pending 04-Dec-2020 000000000 0
US-20220164535-A1 Classification code parser Pending 25-Nov-2020 0000000000
EP-3796333-A1 Unbiased etl system for timed medical event prediction Pending 20-Sep-2019 000000000 0
US-20210090745-A1 Unbiased etl system for timed medical event prediction Pending 20-Sep-2019 000000000
US-20200410614-A1 Machine learning techniques for automatic evaluation of clinical trial data Pending 25-Jun-2019 G16H10/60
To view IQVIA’s complete patent history, request access »

IQVIA Executive Team (88)

Name Title Board Seat Contact Info
Ari Bousbib Chief Executive Officer & Chairman
Costa Panagos President
Frank Wartenberg President
Kevin Knightly President
Alistair Grenfell President, Europe, Middle East, Africa and South Asia
You’re viewing 5 of 88 executive team members. Get the full list »

IQVIA Board Members (20)

Name Representing Role Since
000 0000000 IQVIA Chief Executive Officer & Chairman 000 0000
00000 0000 Self Board Member 000 0000
0000000 0000000 Self Board Member 000 0000
00000 000000 Self Board Member 000 0000
0000 00000000000 Bain Capital Board Member 000 0000
You’re viewing 5 of 20 board members. Get the full list »

IQVIA Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IQVIA Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IQVIA‘s full profile, request access.

Request a free trial

IQVIA Investments & Acquisitions (110)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 01-Jul-2022 0000000000 IT Consulting and Outsourcing
000000 26-Oct-2021 0000000000 Enterprise Systems (Healthcare)
000 000000000 01-Aug-2021 0000000000 Media and Information Services (B2B)
00000000, 000 01-Jul-2021 0000000000 00.000 Other Healthcare Services
Q2 Solutions 01-Apr-2021 Secondary Transaction - Private 00000 Laboratory Services (Healthcare)
You’re viewing 5 of 110 investments and acquisitions. Get the full list »

IQVIA Subsidiaries (40)

Company Name Industry Location Founded
Quality Health (UK) Other Healthcare Services Chesterfield, United Kingdom 2016
000000000 00000000 Biotechnology Marietta, GA 0000
00000 000 Biotechnology Durham, NC 0000
000 00000000000000 Media and Information Services (B2B) Hawthorne, NY 0000
00 000000000 Laboratory Services (Healthcare) Durham, NC 0000
You’re viewing 5 of 40 subsidiaries. Get the full list »